18,077 followers
Long-term outcomes of frontline imatinib therapy for chronic myeloid leukemia in China https://t.co/yrNlre4J5y https://t.co/kJVdRyermL
Long-term outcomes of frontline imatinib therapy for chronic myeloid leukemia in China https://t.co/yrNlre4J5y https://t.co/kJVdRyermL
New research: Long-term outcomes of frontline imatinib therapy for chronic myeloid leukemia in China: Background Imatinib is the first-line therapy recommended for chronic myeloid leukemia (CML) patients in China. We reported a long-term… #oncology https: